PAX Financial Group’s Amgen AMGN Stock Holding History

PAX Financial Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,253	Closed	-$278K	–	116
2019 Q4	$278K	Buy	+1,253	New	+$276K	0.12%	103

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PAX Financial Group's AMGN Position: Q1 2020 in Review

PAX Financial Group sold out of Amgen (AMGN) in Q1 2020, closing a stake of 1,253 shares — an estimated $278K sold.

PAX Financial Group first reported a position in AMGN in Q4 2019 and held it in 1 quarter. The position peaked at $278K in Q4 2019. 2,030 funds tracked by Wall St. Rank hold AMGN as of Q1 2020.

PAX Financial Group reported no remaining Amgen position as of Q1 2020 after selling out during the quarter.
PAX Financial Group sold 1,253 Amgen shares in Q1 2020, an estimated $278K.
PAX Financial Group first reported a position in Amgen in Q4 2019 and held it in 1 quarter.
PAX Financial Group's Amgen position peaked at $278K in Q4 2019.
2,030 funds tracked by Wall St. Rank held Amgen as of Q1 2020.

Based on PAX Financial Group's 13F filing for Q1 2020, filed 28 Apr 2020.